Abstract: A technology that facilitates distribution of scientific data are disclosed. Exemplary implementations may: obtain scientific data from sci-data gathering devices; analyze gathered sci-data to identify and categorize relevant scientific elements in the gathered sci-data; offer the analyzed sci-data via a marketplace in exchange for a monetary value; and deliver the analyzed sci-data via the marketplace in exchange for an acceptable monetary value.

Abstract: The technology described herein includes methods and uses in oil and gas hydraulic fracking for a quaternary ammonium organosilane, and particularly AMOSILQ™ quaternary ammonium organosilane. Uses include coating and treating filters for use in the hydraulic fracking process, premixing in fracking fluid/water; flowback water treatment and proppant coating.

Abstract: Techniques related to the detection or identification of biological cells or substances.

Abstract: Techniques related to the detection or identification of biological cells or substances.

Abstract: Systems, methods, storage media, and computing platforms that facilitate amelioration based on detection of biological cells or biological substances are disclosed. Example implementations may: monitor a scene proximate to a monitoring device; detect a type or class of biological cells and/or substance amongst the in-scene biological cells and/or substances found in a scene proximate to a monitoring device; and respond to the detection in a manner that ameliorates the harmful effects of the detected type or class of biological cells and/or substances.

Abstract: A technology that facilitates distribution of scientific data are disclosed. Exemplary implementations may: obtain scientific data from sci-data gathering devices; analyze gathered sci-data to identify and categorize relevant scientific elements in the gathered sci-data; offer the analyzed sci-data via a marketplace in exchange for a monetary value; and deliver the analyzed sci-data via the marketplace in exchange for an acceptable monetary value.

Abstract: A condition can be diagnosed based on a symptom experienced by a subject and based on a biological sample including nucleic acids. Based on the symptom, a first set of the nucleic acids can be preselected for analysis. A first plurality of the nucleic acids of the first set that are present in the first biological sample can be captured. For each of the captured nucleic acids of the first plurality, an amount of that captured nucleic acid that is present in the first biological sample can be quantified and sequenced and based on the sequence of that captured nucleic acid, an origin of that captured nucleic acid can be identified. An indication can be output of the quantified amount and the identified origin of at least one captured nucleic acid that is present in the first biological sample.

Abstract: A technology that facilitates distribution of scientific data are disclosed. Exemplary implementations may: obtain scientific data from sci-data gathering devices; analyze gathered sci-data to identify and categorize relevant scientific elements in the gathered sci-data; offer the analyzed sci-data via a marketplace in exchange for a monetary value; and deliver the analyzed sci-data via the marketplace in exchange for an acceptable monetary value.

Abstract: The technology described herein includes methods and uses in oil and gas hydraulic fracking for a quaternary ammonium organosilane, and particularly AMOSILQ™ quaternary ammonium organosilane. Uses include coating and treating filters for use in the hydraulic fracking process, premixing in fracking fluid/water; flowback water treatment and proppant coating.

Abstract: A method that facilitates the maintenance (e.g. creation and update) of health-wellness-medical (HWM) profiles of people and provides a social platform focused on HWM matters for a like-minded community, and provides access to databases of HWM matters, HWM products, HWM coaches, and medical professionals.

Abstract: The technology described herein includes methods and uses for quaternary ammonium, specifically an organosilane quaternary ammonium or quat, and particularly AIVIOSILQ™ quat to provide persistent disinfectant and anti-microbial protection. Uses include skin (derma) and medical applications.

Abstract: Described herein are techniques related to the detection and/or identification of biological cells and/or substances. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

Abstract: Described herein are techniques related to the detection and/or identification of biological cells and/or substances. An example of an electronic device is described herein that includes a scene-capture system to obtain an image of a scene that includes cells or substances therein. The example electronic device also includes a biologic detection system to analyze the obtained image and detect and/or identify a biological cell and/or substance amongst the in-scene cells and/or substances and a reporting system to report a detection or identification of a type or class of biological cell and/or substance in the obtained image and/or identification of a particular cells and/or substances. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

Abstract: Disclosed are specific biomarkers that allow for early testing of preeclampsia/HELLP syndrome. Thus, a method is provided predicting preeclampsia in a pregnant woman. Also disclosed is a kit comprising means for assaying a sample from a pregnant woman for the concentrations of the specific biomarkers.

Abstract: A technology that facilitates distribution of scientific data are disclosed. Exemplary implementations may: obtain scientific data from sci-data gathering devices; analyze gathered sci-data to identify and categorize relevant scientific elements in the gathered sci-data; offer the analyzed sci-data via a marketplace in exchange for a monetary value; and deliver the analyzed sci-data via the marketplace in exchange for an acceptable monetary value.

Abstract: Described herein are technologies related to an implementation of a geolocation medical care management system that receives the physical locations of one or more patients from one or more communication devices, accesses personal medical data related to each of the patients and correlates the personal medical data to physical location of each of the patients. Depending on the where or location of a patient is in the process, particular care or service is provided to the patient.

Abstract: A method and a system for processing measurement data for website statistics are provided. The measurement data is processed in parallel bucket writers and stored in buckets. Upon receiving a report request the buckets are processed in parallel bucket queriers to obtain report data.

Abstract: A method and a system for processing measurement data for website statistics are provided. The measurement data is processed in parallel bucket writers and stored in buckets. Upon receiving a report request the buckets are processed in parallel bucket queriers to obtain report data.

Abstract: A condition can be diagnosed based on a symptom experienced by a subject and based on a biological sample including nucleic acids. Based on the symptom, a first set of the nucleic acids can be preselected for analysis. A first plurality of the nucleic acids of the first set that are present in the first biological sample can be captured. For each of the captured nucleic acids of the first plurality, an amount of that captured nucleic acid that is present in the first biological sample can be quantified and sequenced and based on the sequence of that captured nucleic acid, an origin of that captured nucleic acid can be identified. An indication can be output of the quantified amount and the identified origin of at least one captured nucleic acid that is present in the first biological sample.

Abstract: Disclosed are specific biomarkers that allow for early testing of preeclampsia/HELLP syndrome. Thus, a method is provided predicting preeclampsia in a pregnant woman. Also disclosed is a kit comprising means for assaying a sample from a pregnant woman for the concentrations of the specific biomarkers.